FiftyBidsGovernment contracts and grants, in one plain-English search.

Back to search

Forecast

Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)

CDC/ATSDR is inviting research proposals to study risk factors for Amyotrophic Lateral Sclerosis (ALS). Studies on military service, contact sports, traumatic brain injury, neuroinflammation, and infections agents and exposures are encouraged.

FromCenters for Disease Control and Prevention - ERA
Who can applystate governments, counties, cities and townships, special districts (water, fire, parks, etc.), school districts, public colleges and universities and 8 more types
Eligibility notesAdditional Eligibility Information to be included in the NOFO.
How muchup to $500K per award; about 3 awards; $4.5 million total
DeadlineTue, Dec 1, 2026 (estimated) (39 days left)
CategoryHealth
TypeCooperative agreement
Opportunity #RFA-TS-27-018
Assistance listing93.061
PostedWed, Jul 8, 2026

Heads-up: Forecast: not open yet. Dates and amounts are the agency's estimates.

Open the official posting

From the notice

CDC/ATSDR is inviting research proposals to study risk factors for Amyotrophic Lateral Sclerosis (ALS). Studies on military service, contact sports, traumatic brain injury, neuroinflammation, and infections agents and exposures are encouraged. Funding will be for four funding options: Option A - Support research with strong existing evidence such as studies on known environmental or genetic risk factors, research that improves past studies with better data, or investigations linking risk factors to ALS diagnosis and treatment; Option B - Support new and exploratory research on ALS risk factors such as studies on risk factors with little existing evidence or research using innovative methods; Option C - Understand ALS risk in affected populations, such as studies involving military veterans or investigations of ALS risk factors impacting this population; Option D - Analyze biological samples from the Guamanian ALS cluster such as investigation of disease mechanisms and environmental factors, exposure routes, genetic studies and biomarkers and how this could lead to mitigation therapeutics, diagnostics or prevention.

We may have shortened this. The official posting is the record. We are not affiliated with the agency that published it.